Curcumin sensitizes human gastric cancer cells to 5-fluorouracil through inhibition of the NFκB survival-signaling pathway

OncoTargets and Therapy

Volumn 9, Issue , 2016, Pages 7373-7384

  Kang, Yanting ^a   Hu, Wanle ^a   Bai, Encheng ^a   Zheng, Hailun ^a   Liu, Zhiguo ^a   Wu, Jianzhang ^a   Jin, Rong ^a   Zhao, Chengguang ^a   Liang, Guang ^a  

^a WENZHOU MEDICAL UNIVERSITY   (China)

Author keywords

5 FU; Curcumin; Drug resistance; Gastric cancer; NF B

Indexed keywords

CURCUMIN; FLUOROURACIL; I KAPPA B ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MESSENGER RNA; TUMOR NECROSIS FACTOR;

APOPTOSIS; ARTICLE; CANCER RESISTANCE; CYTOSOL; DOWN REGULATION; DRUG ACTIVITY; DRUG POTENTIATION; DRUG SENSITIZATION; FLOW CYTOMETRY; GASTRIC CANCER CELL LINE; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN SURVIVAL SIGNALING PATHWAY; PROTEIN DEGRADATION; PROTEIN LOCALIZATION; PROTEIN TRANSPORT; SGCR CELL LINE; SIGNAL TRANSDUCTION; STOMACH CANCER; WESTERN BLOTTING;

EID: 85006054204     PISSN: None     EISSN: 11786930     Source Type: Journal    
DOI: 10.2147/OTT.S118272     Document Type: Article

References (34)

1. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2015. CA Cancer J Clin. 2015; 65(1): 5-29.
2. Kim DC, Park KR, Jeong YJ, et al. Resistance to the c-Met inhibitor KRC-108 induces the epithelial transition of gastric cancer cells. Oncol Lett. 2016; 11(2): 991-997.
3. Holohan C, Van Schaeybroeck S, Longley DB, Johnston PG. Cancer drug resistance: an evolving paradigm. Nat Rev Cancer. 2013; 13(10): 714-726.
4. Subhash VV, Tan SH, Tan WL, et al. GTSE1 expression represses apoptotic signaling and confers cisplatin resistance in gastric cancer cells. BMC Cancer. 2015; 15: 550.
5. Park MH, Hong JT. Roles of NF-κB in cancer and inflammatory diseases and their therapeutic approaches. Cells. 2016; 5(2): E15.
6. Wang D, Montgomery RB, Schmidt LJ, et al. Reduced tumor necrosis factor receptor-associated death domain expression is associated with prostate cancer progression. Cancer Res. 2009; 69(24): 9448-9456.
7. Wu T, Dai Y. Tumor microenvironment and therapeutic response. Cancer Lett. Epub 2016 Feb 1.
8. Li S, Wang N, Brodt P. Metastatic cells can escape the proapoptotic effects of TNF-α through increased autocrine IL-6/STAT3 signaling. Cancer Res. 2012; 72(4): 865-875.
9. Müerköster S, Arlt A, Witt M, et al. Usage of the NF-κB inhibitor sulfasalazine as sensitizing agent in combined chemotherapy of pancreatic cancer. Int J Cancer. 2003; 104(4): 469-476.
10. Zeng C, Zhong P, Zhao Y, et al. Curcumin protects hearts from FFA-induced injury by activating Nrf2 and inactivating NF-κB both in vitro and in vivo. J Mol Cell Cardiol. 2015; 79: 1-12.
11. Compagno M, Lim WK, Grunn A, et al. Mutations of multiple genes cause deregulation of NF-κB in diffuse large B-cell lymphoma. Nature. 2009; 459(7247): 717-721.
12. Kodela R, Nath N, Chattopadhyay M, Nesbitt DE, Velázquez-Martínez CA, Kashfi K. Hydrogen sulfide-releasing naproxen suppresses colon cancer cell growth and inhibits NF-κB signaling. Drug Des Devel Ther. 2015; 9: 4873-4882.
13. Flynn V Jr, Ramanitharan A, Moparty K, et al. Adenovirus-mediated inhibition of NF-κB confers chemo-sensitization and apoptosis in prostate cancer cells. Int J Oncol. 2003; 23(2): 317-323.
14. Li M, Zhang Z, Hill DL, Wang H, Zhang R. Curcumin, a dietary component, has anticancer, chemosensitization, and radiosensitization effects by down-regulating the MDM2 oncogene through the PI3K/mTOR/ETS2 pathway. Cancer Res. 2007; 67(5): 1988-1996.
15. Narasimhan M, Ammanamanchi S. Curcumin blocks RON tyrosine kinase-mediated invasion of breast carcinoma cells. Cancer Res. 2008; 68(13): 5185-5192.
16. Xiao J, Sheng X, Zhang X, Guo M, Ji X. Curcumin protects against myocardial infarction-induced cardiac fibrosis via SIRT1 activation in vivo and in vitro. Drug Des Devel Ther. 2016; 10: 1267-1277.
17. Koo JY, Kim HJ, Jung KO, Park KY. Curcumin inhibits the growth of AGS human gastric carcinoma cells in vitro and shows synergism with 5-fluorouracil. J Med Food. 2004; 7(2): 117-121.
18. Pandey A, Vishnoi K, Mahata S, et al. Berberine and curcumin target survivin and STAT3 in gastric cancer cells and synergize actions of standard chemotherapeutic 5-fluorouracil. Nutr Cancer. 2015; 67(8): 1293-1304.
19. Bayet-Robert M, Kwiatkowski F, Leheurteur M, et al. Phase I dose escalation trial of docetaxel plus curcumin in patients with advanced and metastatic breast cancer. Cancer Biol Ther. 2010; 9(1): 8-14.
20. Mahammedi H, Planchat E, Pouget M, et al. The new combination docetaxel, prednisone and curcumin in patients with castration-resistant prostate cancer: a pilot phase ii study. Oncology. 2016; 90(2): 69-78.
21. Ware KE, Hinz TK, Kleczko E, et al. A mechanism of resistance to gefitinib mediated by cellular reprogramming and the acquisition of an FGF2-FGFR1 autocrine growth loop. Oncogenesis. 2013; 2: e39.
22. Obenauf AC, Zou Y, Ji AL, et al. Therapy-induced tumour secretomes promote resistance and tumour progression. Nature. 2015; 520(7547): 368-372.
23. Kunnumakkara AB, Guha S, Krishnan S, Diagaradjane P, Gelovani J, Aggarwal BB. Curcumin potentiates antitumor activity of gemcitabine in an orthotopic model of pancreatic cancer through suppression of proliferation, angiogenesis, and inhibition of nuclear factor-κB-regulated gene products. Cancer Res. 2007; 67(8): 3853-3861.
24. Yang J, Lin Y, Guo Z, et al. The essential role of MEKK3 in TNF-induced NF-κB activation. Nat Immunol. 2001; 2(7): 620-624.
25. Bao C, Li Y, Huan L, et al. NF-κB signaling relieves negative regulation by miR-194 in hepatocellular carcinoma by suppressing the transcription factor HNF-1α. Sci Signal. 2015; 8(387): ra75.
26. Camargo RG, Riccardi DM, Ribeiro HQ, et al. NF-κB p65 and expression of its pro-inflammatory target genes are upregulated in the subcutaneous adipose tissue of cachectic cancer patients. Nutrients. 2015; 7(6): 4465-4479.
27. Bivona TG, Hieronymus H, Parker J, et al. FAS and NF-κB signalling modulate dependence of lung cancers on mutant EGFR. Nature. 2011; 471(7339): 523-526.
28. Bimonte S, Barbieri A, Leongito M, et al. Curcumin anticancer studies in pancreatic cancer. Nutrients. 2016; 8(7): E433.
29. Charpentier MS, Whipple RA, Vitolo MI, et al. Curcumin targets breast cancer stem-like cells with microtentacles that persist in mammospheres and promote reattachment. Cancer Res. 2014; 74(4): 1250-1260.
30. Yde CW, Emdal KB, Guerra B, Lykkesfeldt AE. NFκB signaling is important for growth of antiestrogen resistant breast cancer cells. Breast Cancer Res Treat. 2012; 135(1): 67-78.
31. Dai Y, Lawrence TS, Xu L. Overcoming cancer therapy resistance by targeting inhibitors of apoptosis proteins and nuclear factor-kappa B. Am J Transl Res. 2009; 1(1): 1-15.
32. Cilloni D, Messa F, Arruga F, et al. The NF-κB pathway blockade by the IKK inhibitor PS1145 can overcome imatinib resistance. Leukemia. 2006; 20(1): 61-67.
33. Lundqvist J, Yde CW, Lykkesfeldt AE. 1α,25-Dihydroxyvitamin D3 inhibits cell growth and NFκB signaling in tamoxifen-resistant breast cancer cells. Steroids. 2014; 85: 30-35.
34. Hutti JE, Pfefferle AD, Russell SC, Sircar M, Perou CM, Baldwin AS. Oncogenic PI3K mutations lead to NF-κB-dependent cytokine expression following growth factor deprivation. Cancer Res. 2012; 72(13): 3260-3269.